We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$9.57M
Cap. Flow
+$7.18M
Cap. Flow %
6.85%
Top 10 Hldgs %
21.25%
Holding
64
New
2
Increased
53
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$2.23M
2
ADP icon
Automatic Data Processing
ADP
+$2.14M
3
CAH icon
Cardinal Health
CAH
+$193K
4
GD icon
General Dynamics
GD
+$142K
5
ABBV icon
AbbVie
ABBV
+$135K

Top Sells

Rank Stock Value
1
ARE icon
Alexandria Real Estate Equities
ARE
+$1.05M
2
TFC icon
Truist Financial
TFC
+$927K
3
LMT icon
Lockheed Martin
LMT
+$304K
4
GILD icon
Gilead Sciences
GILD
+$109K
5
AES icon
AES
AES
+$81.1K

Sector Composition

Rank Sector Weight
1 Financials 21.5%
2 Healthcare 14.65%
3 Industrials 12.71%
4 Technology 11.77%
5 Energy 9.24%

No holdings matched the selected filter criteria.

1 2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
HA
Helium Advisors Everett, Washington $105M AUM 15.41% 1-Year Est. Return
SDP
Sentinel Dome Partners Burlingame, California $105M AUM
MAM
McLaughlin Asset Management Danville, Illinois $105M AUM
AF
Aldebaran Financial $105M AUM 19.84% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Weaver C. Barksdale & Associates held 64 positions worth $105M, up 10% from $95.3M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates deployed $7.18M of net new capital in Q1 2026, opening 2 new positions and adding to 53 existing holdings. Its largest new stake was Accenture: 9,590 shares worth $1.9M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Lockheed Martin, an estimated $304K trimmed.

  • Weaver C. Barksdale & Associates's largest Q1 2026 buy was Accenture: 9,590 shares worth $1.9M.
  • Weaver C. Barksdale & Associates added most to Cardinal Health in Q1 2026, an estimated $193K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2026 reduction was Lockheed Martin, cutting an estimated $304K.
  • Weaver C. Barksdale & Associates fully exited Alexandria Real Estate Equities in Q1 2026, selling an estimated $1.05M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $105M portfolio in Q1 2026.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q1 2026.
  • Weaver C. Barksdale & Associates's portfolio value rose 10% quarter-over-quarter to $105M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.